SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042058
Filing Date
2023-08-14
Accepted
2023-08-14 07:30:36
Documents
64
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q grtx-20230630.htm   iXBRL 10-Q 2057709
2 EX-31.1 grtx-ex31_1.htm EX-31.1 18936
3 EX-31.2 grtx-ex31_2.htm EX-31.2 21924
4 EX-32.1 grtx-ex32_1.htm EX-32.1 10583
5 EX-32.2 grtx-ex32_2.htm EX-32.2 9355
  Complete submission text file 0000950170-23-042058.txt   7153383

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grtx-20230630.xsd EX-101.SCH 43367
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grtx-20230630_pre.xml EX-101.PRE 258703
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grtx-20230630_def.xml EX-101.DEF 118264
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grtx-20230630_lab.xml EX-101.LAB 373655
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT grtx-20230630_cal.xml EX-101.CAL 37410
58 EXTRACTED XBRL INSTANCE DOCUMENT grtx-20230630_htm.xml XML 1300058
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39114 | Film No.: 231166266
SIC: 2834 Pharmaceutical Preparations